These findings suggest that CD74 may be involved in the inflammatory response to COVID-19, although it may not be useful as a prognostic marker for severe COVID-19 disease, and that further studies are needed to explore the potential role of CD74 in the pathogenesis of COVID-19 and the feasibility of its use as a therapeutic target. This evidence concerns the gene CD74 and COVID-19.